Our ultimate goal is to develop standardized and a hopefully simple treatment for patients with C. difficile colitis that utilizes elements of bacterial flora normally resident in the lower human GI tract. Realization of this goal may have commercial im
|Effective start/end date||3/1/09 → 2/28/11|
- MN MED FDN
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.